Carey K. Anders

16.7k citations

211 papers · 8.7k indexed · 6 hit papers · h-index 45

Impact in

Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Risks and Factors
- Cancer Immunotherapy and Biomarkers
Cancer Research top 0.5%
- Breast Cancer Treatment Studies

Papers in

Oncology 159
- Lung Cancer Research Studies 51
- Cancer Treatment and Pharmacology 50
- HER2/EGFR in Cancer Research 42
Pulmonary and Respiratory Medicine 137
- Brain Metastases and Treatment 84
- Advanced Breast Cancer Therapies 52
- Lung Cancer Treatments and Mutations 23

Co-authors: Lisa A. Carey Charles M. Perou Rebecca H. Johnson Jennifer K. Litton Archie Bleyer Marianne Phillips Aleix Prat Bárbara Adamo
Journals: Journal of Clinical Oncology (48 papers)Cancer Research (20 papers)Clinical Cancer Research (9 papers)Clinical Breast Cancer (8 papers)Breast Cancer Research and Treatment (8 papers)
Partner nations: United States France United Kingdom

In The Last Decade

Carey K. Anders

197 papers receiving 8.5k citations

Hit Papers

6 papers align trajectories log scale

Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update 2022 · 116 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Journal of Clinical Oncology
2019 Nature Reviews Disease Primers
2019 JAMA Oncology
2009 Seminars in Oncology
2009 Clinical Breast Cancer
2008 Journal of Clinical Oncology

Peers

Countries citing papers authored by Carey K. Anders

Since Specialization

Citations

This map shows the geographic impact of Carey K. Anders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carey K. Anders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carey K. Anders more than expected).

Fields of papers citing papers by Carey K. Anders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carey K. Anders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carey K. Anders. The network helps show where Carey K. Anders may publish in the future.

Co-authors

The 25 scholars most cited alongside Carey K. Anders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carey K. Anders Line = papers co-authored together Carey K. Anders links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real-World Clinical Outcomes in Patients With HER2+ Metastatic Breast Cancer Receiving Tucatinib-Based Therapy After 2 or More Prior Metastatic HER2-Directed Regimens Cancer Control ·Carey K. Anders, R Dhanesh, Karen Bartley, Tasmia Sharna, Nathan Ron, Shu Wang, Wataru Sase	2025	0
2	Real-world clinical outcomes in patients with HER2+ metastatic breast cancer receiving tucatinib therapy after 2 or more prior HER2-directed therapies European Journal of Cancer ·Carey K. Anders, R Dhanesh, Karen Bartley, Trine Rygvold Waage, A. Sow, Sheng Wang, Peter A. Kaufman	2024	1
3	Effect of Breast Cancer Receptor Subtypes and CSF Cytology Status on Survival of Patients With Leptomeningeal Disease Clinical Breast Cancer ·گودرز افتخار جهرمی, Shakhila. S. S, Andrea Baran, Ruth O’Regan, V. Ažušilis, Huina Zhang, Sara Hardy, Nimish Mohile, Carey K. Anders, La Granja Farm.	2024	0
4	The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice Clinical Cancer Research ·Alex Broom, B Arnould, Katherine Kenny, Aidan A. Higgins, Michelle Peterie, Μάρκος Χαλκιαδάκης, 李福山 LI Fu-shan, S GLEDHILL, Eric Lipp, Aaron C. Tan, Kyle M. Walsh, Brent A. Hanks, Margaret Johnson, Amanda E.D. Van Swearingen, Carey K. Anders, David M. Ashley, Mustafa Khasraw	2023	7
5	Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases Breast Cancer Research and Treatment ·Clement Owusu-Cole, Y Antoniuk, Mobin Naqshbandi, Carey K. Anders, Maria J. Sambade, Allison M. Deal, Dimitri G. Trembath, Горностаева Татьяна Николаевна, Edi Brogi, Andrew D. Seidman	2023	2
6	Cytotoxic Engineered Induced Neural Stem Cells as an Intravenous Therapy for Primary Non–Small Cell Lung Cancer and Triple-Negative Breast Cancer Molecular Cancer Therapeutics ·Eugene Horowitz, Laszlo Mero, Juli R. Bagó, F. M. Weida, Nandikonda Geetha Reddy, Satapom, Stephanie A. Montgomery, Kevin Sheets, Carey K. Anders, Shawn Hingtgen	2021	2
7	A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer Clinical Cancer Research ·Sara M. Tolaney, Solmaz Sahebjam, Émilie Le Rhun, Thomas Bachelot, Peter Kabos, Ahmad Awada, Denise A. Yardley, Arlene Chan, Pierfranco Conté, Véronique Dièras, Nancy U. Lin, 純子西周, Sonya C. Chapman, Zhengyu Yang, Yanyun Chen, Carey K. Anders	2020	144
8	ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases Clinical Cancer Research ·Priya Kumthekar, Shou‐Ching Tang, Andrew Brenner, Santosh Kesari, David Piccioni, Carey K. Anders, Jose Carrillo, Pavani Chalasani, Peter Kabos, Shannon Puhalla, Katherine Tkaczuk, Agustin Garcia, Manmeet S. Ahluwalia, Jeffrey S. Wefel, Nehal J. Lakhani, Nuhad K. Ibrahim	2020	178
9	Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16INK4a JNCI Cancer Spectrum ·Shlomit Strulov Shachar, Allison M. Deal, Katherine E. Reeder‐Hayes, Kirsten A. Nyrop, Natalia Mitin, Carey K. Anders, Lisa A. Carey, Elizabeth Claire Dees, Trevor A. Jolly, Gretchen Kimmick, Meghan Karuturi, Raquel E. Reinbolt, Yaser Aldhabyani, Hyman B. Muss	2020	21
10	Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice Cancer ·Kirsten A. Nyrop, Allison M. Deal, 有子ムラタ, Shlomit Strulov Shachar, Bryce B. Reeve, Ethan Basch, Seul Ki Choi, Jordan T. Lee, William A. Wood, Carey K. Anders, Lisa A. Carey, Elizabeth Claire Dees, Trevor A. Jolly, Gretchen Kimmick, Meghan Karuturi, Raquel E. Reinbolt, Gary Ellison, Hyman B. Muss	2019	65
11	Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ npj Breast Cancer ·Sunil Kumar, Daniel Lindsay, Jiachun Chen, Amy Garrett, Xianming Tan, Carey K. Anders, Lisa A. Carey, Gaorav P. Gupta	2018	33
12	Abemaciclib for the treatment of brain metastases (BM) secondary to hormone receptor positive (HR+), HER2 negative breast cancer. Journal of Clinical Oncology ·Sara M. Tolaney, Nancy U. Lin, Donald Thornton, Suzanne Klise, Timothy M. Costigan, P. Kellie Turner, Carey K. Anders	2017	41
13	Live birth outcomes after adolescent and young adult breast cancer International Journal of Cancer ·Chelsea Anderson, Stephanie M. Engel, Carey K. Anders, Hazel B. Nichols	2017	20
14	Biology and Etiology of Young-Onset Breast Cancers among Premenopausal African American Women: Results from the AMBER Consortium Cancer Epidemiology Biomarkers & Prevention ·Lynn Chollet‐Hinton, Andrew F. Olshan, Hazel B. Nichols, Carey K. Anders, Jennifer L. Lund, Emma H. Allott, Traci N. Bethea, Chi-Chen Hong, Stephanie M. Cohen, Thaer Khoury, Gary Zirpoli, Virginia F. Borges, Lynn Rosenberg, Elisa V. Bandera, Christine B. Ambrosone, Julie R. Palmer, Melissa A. Troester	2017	26
15	OS7.2 A Phase II Study of ANG1005, a novel BBB/BCB Penetratant Taxane in Patients with Recurrent Brain Metastases and Leptomeningeal Carcinomatosis from Breast Cancer Neuro-Oncology ·Priya Kumthekar, Shou‐Ching Tang, Andrew Brenner, Santosh Kesari, Carey K. Anders, Jose Carrillo, Pavani Chalasani, Peter Kabos, Manmeet S. Ahluwalia, Nuhad K. Ibrahim	2016	7
16	Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA -Mutated and BRCA –Wild-Type Triple-Negative Breast Cancer Molecular Cancer Therapeutics ·Olga Karginova, Marni B. Siegel, Amanda E.D. Van Swearingen, Allison M. Deal, Bárbara Adamo, Maria J. Sambade, Hua Ni-na, Nana Nikolaishvili‐Feinberg, Ryan Bash, Sara O’Neal, 孙芙蓉, Joel S. Parker, Charlene Santos, David B. Darr, William C. Zamboni, Yueh Z. Lee, C. Ryan Miller, Carey K. Anders	2015	53
17	αB-Crystallin: A Novel Regulator of Breast Cancer Metastasis to the Brain Clinical Cancer Research ·Dmitry Malin, Elena Strekalova, Vladimír Petrovič, Allison M. Deal, Abraham Al Ahmad, Bárbara Adamo, C. Ryan Miller, Andrey Ugolkov, Chad Livasy, Karen Fritchie, Erika Hamilton, Kimberly Blackwell, Joseph Geradts, Kassiane Moreira Joaquim, Lisa A. Carey, Eric V. Shusta, Carey K. Anders, Vincent L. Cryns	2013	81
18	Breast Cancer in Adolescents and Young Adults: A Review With a Focus on Biology Journal of the National Comprehensive Cancer Network ·一良田島, Elgene Lim, Carey K. Anders	2013	58
19	Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer The Oncologist ·Aleix Prat, Bárbara Adamo, Maggie C.U. Cheang, Carey K. Anders, Lisa A. Carey, Charles M. Perou	2013	403
20	Understanding and treating triple-negative breast cancer. PubMed ·Carey K. Anders, Lisa A. Carey	2008	206

About Carey K. Anders

Carey K. Anders is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Reproductive Medicine, having authored 211 papers that have together received 8.7k indexed citations. Recurring topics across this work include Brain Metastases and Treatment (84 papers), Advanced Breast Cancer Therapies (52 papers), Lung Cancer Research Studies (51 papers), Cancer Treatment and Pharmacology (50 papers), HER2/EGFR in Cancer Research (42 papers), Breast Cancer Treatment Studies (41 papers), Lung Cancer Treatments and Mutations (23 papers) and Glioma Diagnosis and Treatment (20 papers). The work is most often cited by research in Oncology (5.4k citations), Cancer Research (2.6k citations), Genetics (954 citations), Pulmonary and Respiratory Medicine (2.8k citations) and Reproductive Medicine (486 citations). Carey K. Anders has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Lisa A. Carey, Charles M. Perou, Rebecca H. Johnson, Jennifer K. Litton, Archie Bleyer, Marianne Phillips, Aleix Prat, Bárbara Adamo, Millie A. Behera and Maggie C.U. Cheang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Clinical Breast Cancer and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact